-
Founded in:
2000-01-14 -
Country:
China -
Address:
Yingshang Industrial Development Zone, Fuyang City, Anhui Province -
Tax NO.:
91341226738907020P -
Registered Funds:
30 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pancreatin |
Contains pancreatic lipase, pancreatic amylase and trypsin, which can break down fat, starch and protein respectively to promote digestion
More
Contains pancreatic lipase, pancreatic amylase and trypsin, which can break down fat, starch and protein respectively to promote digestion |
300mg | 8049-47-6 | 27 |
| Pepsin |
Can convert protein into protein and peptone, promoting digestion
More
Can convert protein into protein and peptone, promoting digestion |
13mg | 9001-75-6 | 21 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Midecamycin A1 |
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria.
More
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria. |
0 | ||
| Sineptina A6 |
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria.
More
The antibacterial property is similar to that of erythromycin. It has a strong antibacterial effect on Gram-positive bacteria, and is effective against Staphylococcus, Streptococcus pyogenes, Streptococcus viridans, Streptococcus pneumoniae, Diphtheria bacillus, Tetanus bacillus, and anthrax bacillus. It also has antibacterial effects on Gram-negative bacteria such as gonococci and pertussis bacillus. It is also effective against Leptospira, Rickettsia, and Mycoplasma. It can be used as a substitute for erythromycin for infections of the oropharynx, respiratory tract, skin and soft tissue, and bile duct caused by the above-mentioned sensitive bacteria. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lincomycin hydrochloride |
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.
More
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria. |
859-18-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Lincomycin hydrochloride |
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.
More
It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance with penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. It acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria. |
859-18-7 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin phosphate |
This product is a chemically semi-synthetic clindamycin derivative. After entering the body, it is rapidly hydrolyzed into clindamycin to show its pharmacological activity. The antibacterial spectrum, antibacterial activity and therapeutic effect are the same as those of clindamycin, but its fat solubility and permeability are better than those of clindamycin, and it can be administered by intramuscular injection and intravenous drip. Compared with lincomycin, this product has a 4-8 times stronger antibacterial effect, good absorption, high bone concentration, and good efficacy against anaerobic infections. It has strong antibacterial activity mainly against Gram-positive cocci and anaerobic bacteria.
More
This product is a chemically semi-synthetic clindamycin derivative. After entering the body, it is rapidly hydrolyzed into clindamycin to show its pharmacological activity. The antibacterial spectrum, antibacterial activity and therapeutic effect are the same as those of clindamycin, but its fat solubility and permeability are better than those of clindamycin, and it can be administered by intramuscular injection and intravenous drip. Compared with lincomycin, this product has a 4-8 times stronger antibacterial effect, good absorption, high bone concentration, and good efficacy against anaerobic infections. It has strong antibacterial activity mainly against Gram-positive cocci and anaerobic bacteria. |
24729-96-2 | 33 |